Leo Cancer Care develops radiation therapy technologies that support cancer treatment in an upright patient position.
Leo Cancer Care has raised $65.0M in total funding. The most recent round was Series D. The last funding was announced in July 2026.
Leo Cancer Care's investors include Alumni Ventures, Catalio Capital Management, Serra Ventures, Yu Galaxy, Eventide.
Leo Cancer Care is headquartered in Harley, United Kingdom.
Leo Cancer Care develops radiation therapy technologies that support cancer treatment in an upright patient position.
Leo Cancer Care is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Leo Cancer Care — Funding & Investors." VCBacked, July 8, 2026, https://www.vcbacked.co/company/leo-cancer-care. Accessed October 17, 2026.
VCBacked. (2026). Leo Cancer Care — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/leo-cancer-care
{{cite web |title=Leo Cancer Care — Funding & Investors |url=https://www.vcbacked.co/company/leo-cancer-care |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated